Australia markets closed

BridgeBio Pharma, Inc. (BBIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
27.74+0.71 (+2.63%)
At close: 04:00PM EDT
27.60 -0.14 (-0.50%)
Pre-market: 05:52AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
375,935
376,689
393,772
356,082
Other short-term investments
58,949
95,233
442,891
251,011
Total cash
434,884
471,922
836,663
607,093
Other current assets
24,305
21,922
-
-
Total current assets
477,593
548,853
888,858
642,824
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
19,843
25,247
45,973
36,833
Net property, plant and equipment
19,843
25,247
45,973
36,833
Equity and other investments
-
-
-
0
Intangible assets
-
28,712
44,934
-
Other long-term assets
22,625
20,224
33,027
23,931
Total non-current assets
68,787
74,183
123,934
60,764
Total assets
546,380
623,036
1,012,792
703,588
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
-
1,458
Accounts payable
10,655
11,558
11,884
8,945
Accrued liabilities
65,595
66,783
81,206
46,218
Deferred revenues
6,096
8,156
0
-
Other current liabilities
-
-
-
5,550
Total current liabilities
143,844
121,428
135,069
95,648
Non-current liabilities
Long-term debt
1,726,729
1,707,615
1,703,805
475,857
Other long-term liabilities
9,361
26,643
22,069
9,520
Total non-current liabilities
1,745,071
1,746,532
1,743,302
500,054
Total liabilities
1,888,915
1,867,960
1,878,371
595,702
Stockholders' equity
Common stock
181
157
154
125
Retained earnings
-2,560,501
-1,918,149
-1,436,966
-888,755
Accumulated other comprehensive income
31
-328
-132
192
Total stockholders' equity
-1,354,257
-1,254,617
-870,414
57,906
Total liabilities and stockholders' equity
546,380
623,036
1,012,792
703,588